Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study

Table 2

Clinical characteristics of CLEAR Class 1 and Class 2 UM patients who experienced metastasis.

Patient	Class	Age	Ciliary body involvement	Largest basal diameter (mm)	Primary tumor treatment	Metastatic location (s)	Time to metastasis (yrs)	Time to death (yrs)	Follow-up (yrs)
CLASS 1
1	1	75	No	9.4	None	Liver/lungs	3.24	3.27	3.27
2	1	53	Yes	18.5	Enucleation	Liver	4.37	5.86	6.18
CLASS 2
1	2	31	Yes	18.2	Enucleation	Liver	1.37	N/A	1.37
2	2	84	No	9.1	Enucleation	Liver	6.77	N/A	7.83
3	2	48	No	23	Enucleation	Bone	1.11	N/A	1.71
4	2	74	Yes	14.8	Enucleation	Bone	1.31	N/A	1.36
5	2	77	No	19.9	Enucleation	Liver/lungs	0.85	N/A	1.32
6	2	54	No	20.8	Enucleation	Liver	1.47	N/A	1.95
7	2	61	No	11.9	Plaque	Bone	2.45	N/A	2.51
8	2	86	No	17.6	Enucleation	Liver	1.21	1.47	1.47
9	2	59	No	4.9	TTT	Liver	3.78	3.69	3.69
10	2	50	No	18	Enucleation	Liver	1.27	1.69	1.69
11	2	83	No	14.6	Plaque	Liver	3.19	3.5	3.5
12	2	54	No	12.6	Enucleation	Lungs/brain	2.57	2.66	2.66
Class 2
Median							1.42	2.66	1.83